Wall Street Zen Upgrades Astrotech (NASDAQ:ASTC) to Sell

Astrotech (NASDAQ:ASTC) was upgraded by Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Astrotech in a report on Monday, August 24th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Astrotech has a consensus rating of “Sell”.

Astrotech Price Performance

Shares of Astrotech stock opened at $5.04 on Friday. The stock’s fifty day moving average is $6.77 and its two-hundred day moving average is $9.01. The company has a market capitalization of $10.13 million, a PE ratio of -0.59 and a beta of 4.91. Astrotech has a 52 week low of $1.91 and a 52 week high of $68.85.

Institutional Trading of Astrotech

Institutional investors and hedge funds have recently bought and sold shares of the business. J. Safra Sarasin Holding AG purchased a new stake in Astrotech in the first quarter valued at $140,000. BlackRock Inc. acquired a new position in shares of Astrotech in the 2nd quarter valued at about $220,000. Finally, SCS Capital Management LLC acquired a new position in shares of Astrotech in the 2nd quarter valued at about $120,000. 24.35% of the stock is currently owned by institutional investors and hedge funds.

About Astrotech

Astrotech Corporation (NASDAQ: ASTC) is a technology company focused on the development and commercialization of mass spectrometry systems. Through its subsidiaries, the company designs compact analytical instruments intended to identify and measure chemical compounds in applications including security, defense, industrial testing, agriculture and breath analysis.

Astrotech’s technology portfolio has included products such as the TRACER 1000 explosives and narcotics detection system, AgLAB instruments for agricultural and industrial analysis, and BreathTech systems designed to analyze compounds in human breath.